Sodium valproate: who knew what and when? Cumulative meta-analysis gives extra insights
Sodium valproate is licensed in the EU for treating generalized, partial, or other forms of epilepsy. It has also been used to treat bipolar disorder and to prevent migraine. In February of this year, the European Medicines Agency recommended that sodium valproate should not be used during pregnancy...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2018
|